why choose us

300×250 Ad Slot

Research Article: Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials

Date Published: 2023-12-05

Abstract:
Leukemia is a group of malignant disorders which affect the blood and blood-forming tissues in the bone marrow, lymphatic system, and spleen. Many types of leukemia exist; thus, their diagnosis and treatment are somewhat complicated. The use of conventional strategies for treatment such as chemotherapy and radiotherapy may develop many side effects and toxicity. Hence, modern research is concerned with the development of specific nano-formulations for targeted delivery of anti-leukemic drugs avoiding toxic effects on normal cells. Nanostructures can be applied not only in treatment but also in diagnosis. In this article, types of leukemia, its causes, diagnosis as well as conventional treatment of leukemia shall be reviewed. Then, the use of nanoparticles in diagnosis of leukemia and synthesis of nanocarriers for efficient delivery of anti-leukemia drugs being investigated in in vivo and clinical studies. Therefore, it may contribute to the discovery of novel and emerging nanoparticles for targeted treatment of leukemia with less side effects and toxicities.

Introduction:
Leukemia is a class of cancerous diseases that impact the bone marrow, lymphatic system, spleen, and blood-forming organs. It causes one type of leukocyte, i.e., white blood cell or WBC, to proliferate tremendously resulting in leukocytosis. Leukocytosis is a typical response to infection; but, when it persists over an extended period of time or increases gradually without an apparent reason, it may be a sign of cancer [1]. Leukemia comes in a variety of forms, some of which are more prevalent in young patients,…

Read more

300×250 Ad Slot